Сообщения

Сообщения за 2017

More

More
Army Sgt. Bowe Bergdahl's guilty pleas on charges of endangering comrades in Afghanistan have set up a dramatic sentencing hearing later this month that could land him in prison for life.

from Biotech News

Dow Jones tops 23,000, fuelled by corporate earnings

Dow Jones tops 23,000, fuelled by corporate earnings
The Dow Jones Industrial Average passed another milestone, topping 23,000 for the first time, as strong earnings from UnitedHealth Group and Johnson & Johnson helped push the more than century-old gauge to a record. It's the sixth 1000-point milestone reached in the past 12 months and the fifth since Donald Trump was elected president in November.

from Biotech News

Johnson & Johnson tops Street 3Q forecasts, hikes forecast

Johnson & Johnson tops Street 3Q forecasts, hikes forecast
The New Brunswick, New Jersey, company had profit of $1.37 per share. Earnings, adjusted for amortization costs and costs related to mergers and acquisitions, came to $1.90 per share.

from Biotech News

Johnson & Johnson tops Street 3Q forecasts, hikes forecast

Johnson & Johnson tops Street 3Q forecasts, hikes forecast
In this July 16, 2012 file photo, Johnson & Johnson products are displayed in Orlando, Fla. Johnson & Johnson reports earnings, Tuesday, Oct. 17, 2017.

from Biotech News

Biotech Analysis Central: Daily Pharma News - October 17, 2017

Biotech Analysis Central: Daily Pharma News - October 17, 2017
Bristol-Myers Squibb achieves encouraging data in small cell lung cancer patients with both Opdivo alone and in combination with Yervoy Welcome to Biotech Analysis Central Daily News, a daily news report and analysis about what has happened lately in the biotech industry. News: On Monday, Exelixis with its partner Ipsen announced that its phase 3 trial, known as CELESTIAL, met its primary endpoint of overall survival .

from Biotech News

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings
Th... )--Regulatory News: Pershing Square Holdings, Ltd. today announces that it has purchased, through PSH's agent, Jefferies International Limited ,... )--Today from APICS 2017, the premier event for supply chain, logistics and operations management professionals, the supply chain association, APICS, announced the launch... )--IGeneX Inc., a CLIA and New York-approved Reference Laboratory, specializing in testing for tick-borne diseases, is pleased to announce the launch of three new t... )--A.M. Best has released enhancements to the BestLink online platform to fully integrate recent Best's Credit Rating Methodology updates into Best's Insurance Reports... IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Navient Corporation and Encourages Investors with Losses to Contact the Firm )--Lundin Law PC, a shareholder rights firm, announces the ... (more)

from Biotech N…

Novartis division closing Broomfield operations

Novartis division closing Broomfield operations
Novartis, a global health care company based in Switzerland, is closing its Sandoz division in Broomfield at 2555 W. Midway Blvd. The site is a manufacturing facility for generic drugs. Approximately 450 jobs will be affected as a result of the closure, Novartis spokeswoman Sofina Mirza-Reid said this morning.

from Biotech News

Study: Heart risks of gestational diabetes can be lowered

Study: Heart risks of gestational diabetes can be lowered
Women who have had gestational diabetes may be able to reduce or even eliminate their risk for heart problems by eating better, exercising more and adopting other healthy habits in the years after giving birth, according to a study by researchers at the National Institutes of Health.

from Biotech News

Discovery Communications, Inc. (DISCA) Upgraded at Zacks Investment Research

Discovery Communications, Inc. (DISCA) Upgraded at Zacks Investment Research
According to Zacks, "Shares of Discovery Communications have underperformed its industry on a year-to-date basis. In fact, the company has been struggling with declining advertisement revenues for quite some time.

from Biotech News

Finanzen: Strompreis : Strompreise

Strompreise können sich je nach Anbieter stark unterscheiden. Bei den Kosten pro Kilowattstunde kommt es aber auch darauf an, wo Sie wohnen.

from Finanztip Feed
Supported by Video Collection

Finanzen: Wie lange kann ich Arbeitslosengeld beziehen? : Bezugsdauer Arleitslosengeld

from Finanztip Feed
Supported by Video Collection

Analysts Set Merck KGaA (MRK) PT at $109.43

Analysts Set Merck KGaA (MRK) PT at $109.43
Shares of Merck KGaA have received an average rating of "Hold" from the twenty-four ratings firms that are covering the stock, MarketBeat reports. Thirteen investment analysts have rated the stock with a hold rating and eleven have issued a buy rating on the company.

from Biotech News

Northern Trust Corp Acquires 14,353 Shares of Neogen Corporation

Northern Trust Corp Acquires 14,353 Shares of Neogen Corporation
Northern Trust Corp grew its holdings in Neogen Corporation by 2.8% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 530,832 shares of the company's stock after purchasing an additional 14,353 shares during the quarter.

from Biotech News

Head-To-Head Analysis: AC Immune SA

Head-To-Head Analysis: AC Immune SA
AC Immune SA and Alnylam Pharmaceuticals are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership. AC Immune SA presently has a consensus price target of $21.67, suggesting a potential upside of 86.62%.

from Biotech News

Quidel Corporation (QDEL) Upgraded to a oeBuya by Zacks Investment Research

Quidel Corporation (QDEL) Upgraded to a oeBuya by Zacks Investment Research
Complete the form below to receive the latest headlines and analysts' recommendationsfor Quidel Corporation with our free daily email newsletter: from a hold rating to a buy rating in a report issued on Friday. The brokerage currently has $50.00 target price on the stock.

from Biotech News

Seattle Genetics, Inc. (SGEN) Insider Clay B. Siegall Sells 18,832 Shares of Stock

Seattle Genetics, Inc. (SGEN) Insider Clay B. Siegall Sells 18,832 Shares of Stock
Seattle Genetics, Inc. insider Clay B. Siegall sold 18,832 shares of the business's stock in a transaction dated Wednesday, October 11th. The shares were sold at an average price of $61.18, for a total value of $1,152,141.76.

from Biotech News

Have Monsanto and the Biotech Industry Turned Natural Bt Pesticides Into GMO "Super Toxins"?

Have Monsanto and the Biotech Industry Turned Natural Bt Pesticides Into GMO "Super Toxins"?
According to biotech lore, the Bt pesticides introduced into many GMO food crops are natural proteins whose toxic activity extends only to narrow groups of insect species . Therefore, says the industry, these pesticides can all be safely eaten, e.g. by humans.

from Biotech News

Post-antibiotic apocalypse' warning as leaders urged to act on drug resistance

Post-antibiotic apocalypse' warning as leaders urged to act on drug resistance
England's chief medical officer has warned of a "post-antibiotic apocalypse" as she issued a call to action urging global leaders to address the growing threat of antibiotic resistance. Without the drugs used to fight infections, common medical interventions such as caesarean sections, cancer treatments and hip replacements would become incredibly "risky", she said.

from Biotech News

Bayer sells units to be able to complete Monsanto takeover

Bayer sells units to be able to complete Monsanto takeover
German pharmaceutical giant Bayer AG has reached a 5.9 billion euro deal to sell parts of its Crop Science unit to German chemical company BASF to alleviate regulatory concerns over its planned takeover of U.S. seed and weed-killer company Monsanto Co. Monsanto last year accepted an offer from Bayer to pay $57 billion to its shareholders and assume $9 billion in debt.Bayer said Friday it's working with authorities with the aim of closing the deal by early 2018.

from Biotech News

Belgian scientists claim Delaware wrongly seized, sold stock

Belgian scientists claim Delaware wrongly seized, sold stock
Delaware officials asked a judge Friday to dismiss a lawsuit filed on behalf of two Belgian scientists who claim the state improperly used its abandoned property laws to seize their shares in a pharmaceutical firm, cheating them out of $12 million when it was acquired by drug giant Merck & Co. in 2014.

from Biotech News

'Double whammy' for Roche as manufacturing patent losses loom

'Double whammy' for Roche as manufacturing patent losses loom
Landmark Roche patents that helped launch the modern biotechnology era end next year, extinguishing a source of billions of dollars in income for the Swiss drugmaker and piling pressure on its new medicines to succeed. Roche's so-called "Cabilly patents" protect a pivotal step in manufacturing therapeutic antibodies, but end on Dec. 18, 2018.

from Biotech News

NIH partners 11 drugmakers to accelerate cancer therapy research

NIH partners 11 drugmakers to accelerate cancer therapy research
REUTERS: The National Institutes of Health said on Thursday it had partnered 11 biopharma companies to help advance a new class of drugs that uses the body's immune system to fight cancer. The five-year public-private research collaboration, called Partnership for Accelerating Cancer Therapies, includes drugmakers AbbVie, Roche Holding AG and Bristol-Myers Squibb.

from Biotech News

3 Stocks Retirees Should Buy on a Market Pullback

3 Stocks Retirees Should Buy on a Market Pullback
At The Motley Fool, we don't believe in timing the market . At the same time, we're only human, and we know human nature.

from Biotech News

4 Biotech Stocks Initiated At Buy: Acceleron, Tesaro, Mirati, Fate

4 Biotech Stocks Initiated At Buy: Acceleron, Tesaro, Mirati, Fate
H.C. Wainwright has initiated bullish coverage of four healthcare stocks headed into the end of 2017. Analyst Edward White explained his positive take on the four stocks in a research note on Thursday.

from Biotech News

Merck Joins with the American Liver Foundation to Educate U.S....

Merck Joins with the American Liver Foundation to Educate U.S....
Chronic HCV infection can slowly damage the liver and may cause serious liver disease decades following initial infection, often without apparent symptoms. Through the initiative, the American Liver Foundation will join events in cities across the country to educate veterans about risk factors for chronic HCV infection, as well as how they can be tested and treated, if appropriate.

from Biotech News

Us Stocks-Dow inches up to record-high on gains in J&J, Wal-Mart

Us Stocks-Dow inches up to record-high on gains in J&J, Wal-Mart
Gains in Wal-Mart and Johnson & Johnson nudged the Dow Jones Industrial Average to another record level on Wednesday, but the broader market was sluggish ahead of big bank earnings. ) rose about 2 percent after Jefferies upgraded the stock to "buy", saying the company's pharma division would help it top analysts' profit estimates.

from Biotech News

Finanzen: Steuererklärung Anlage R : Rentenbesteuerung

Bereits heute müssen rund 4,4 Millionen Rentner Steuern zahlen. Insbesondere nach einer kräftigen Rentenerhöhung können Rentner in die Steuerpflicht rutschen.

from Finanztip Feed
Supported by Video Collection

A 31-year-old built a material that could change the way we reconstruct and heal the body

A 31-year-old built a material that could change the way we reconstruct and heal the body
A company developing a honey-like substance to heal wounds and reconstruct tissue is hoping to change the way we approach certain surgeries. Gecko Biomedical is a Paris-based company that got its start in 2013.

from Biotech News

Finanzen: Autofinanzierung ohne Anzahlung : Autofinanzierung ohne Anzahlung

Auch ohne Eigenkapital können Sie ein Auto finanzieren. Das macht den Kredit teurer und verlängert womöglich die Laufzeit.

from Finanztip Feed
Supported by Video Collection

Stocks are mixed as household goods makers rise, banks fall

Stocks are mixed as household goods makers rise, banks fall
Household goods makers and health care companies are edging higher while banks and energy companies fall Wednesday morning.

from Biotech News

Pharma's Puerto Rico problems could mean drug shortages: FDA chief

Pharma's Puerto Rico problems could mean drug shortages: FDA chief
The head of the U.S. Food and Drug Administration said on Tuesday the country may start to see a small number of drug shortages within two or three weeks due to delays in restoring manufacturing operations in Puerto Rico, where 10 percent of drugs prescribed in the United States are made. Hurricane Maria slammed into the Caribbean island on Sept.

from Biotech News

VERZENIOTM (abemaciclib) Approved for Treatment of Metastatic Breast...

VERZENIOTM (abemaciclib) Approved for Treatment of Metastatic Breast...
Biologics, Inc. , a McKesson Specialty Health oncology pharmacy services company, has been selected by Eli Lilly and Company to be in the limited distribution network for VERZENIOTM , Eli Lilly's first oral oncolytic indicated for metastatic breast cancer. Approved by the U.S. Food and Drug Administration on September 28, 2017, VERZENIO is a CDK inhibitor selective for CDK4 and CDK6.

from Biotech News

Business Highlights

Business Highlights
Initial voting results show that Procter & Gamble successfully fended off an attempt activist investor Nelson Peltz to capture a seat on its board. Peltz, however, is not conceding, calling the vote too close on Tuesday.

from Biotech News

Finanzen: Entschädigung bei Flugausfall : Passagierrechte Flugannullierung

Mit unserem Onlinerechner finden Sie ganz einfach heraus, wie viel Geld Ihnen zusteht, wenn Ihr Flug gestrichen wurde.

from Finanztip Feed
Supported by Video Collection

Vical Announces Completion of the Phase 3 ASP0113 CMV Vaccine Trial

Vical Announces Completion of the Phase 3 ASP0113 CMV Vaccine Trial
Vical Incorporated announced today that the last patient completed their final assessment during the one year follow-up period in the multinational Phase 3 registration trial of ASP0113 in hematopoietic cell transplant recipients. The trial completed enrollment in September 2016 with a total of 515 subjects.

from Biotech News

Gerresheimer mit Umsatz- und Gewinnrückgängen

Gerresheimer mit Umsatz- und Gewinnrückgängen
(dpa-AFX) Gerresheimer hat auch im dritten Quartal die Zurückhaltung der US-Pharmakonzerne zu spüren bekommen. Von Juni bis Ende August sank der Umsatz des Spezialisten für Verpackungen für die Pharma- und Kosmetikindustrie im Jahresvergleich um 5,4 Prozent auf 331,5 Millionen Euro, wie der Konzern ...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Pfizer stellt rezeptfreie Medikamente auf Prüfstand

Pfizer stellt rezeptfreie Medikamente auf Prüfstand
(dpa-AFX) Der US-Pharmariese Pfizer stellt Überlegungen zur Zukunft seiner Sparte mit rezeptfreien Medikamenten an. Für das Geschäft mit der sogenannten Consumer Health - nicht verschreibungspflichtige Mittel für Apotheke und Supermarkt - prüfe man "strategische Alternativen", teilte das Unternehmen...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Advil, Centrum and ChapStick on shopping block

Advil, Centrum and ChapStick on shopping block
Pfizer, one of the world's largest drugmakers, is considering a sale of its consumer healthcare division, a unit that includes well-known brands such as Advil, Centrum, ChapStick, Robitussin and Preparation H. Pfizer said Tuesday morning that it might sell the business outright or spin it off to investors as a separately traded stock. Shares of Pfizer fell slightly on the news.

from Biotech News

Exel-Zellen einen neuen Namen geben

Exel-Zellen einen neuen Namen geben
Klickt man im Office-Kalkulationsprogramm Excel eine Zelle an, wird dessen Name oben links im Programmfenster angezeigt. Normalerweise setzt sich dieser Name aus dem Buchstaben der Spalte sowie der Zeilennummer zusammen (z. B. A10) und kann bei Bedarf auch umbenannt werden.Wenn du einzelnen Zellen neue Namen geben möchtest, dann stehen dir zwei Möglichkeiten zur Verfügung. Markiere die betreffende Zelle und über den Menübefehl Formel | Namen definieren legst du den neuen Zellennamen fest.Die zweite Variante ist wesentlich schneller und einfacher. Klicke die Zelle an, die umbenannt werden soll. Oben links im Namensfeld wird die aktuelle Bezeichnung, zum Beispiel D16, angezeigt.Setze deinen Cursor in das Namensfeld, tippe die neue Bezeichnung ein, und bestätige die Eingabe mit [Enter]. Das war´s schon.Der neue Name darf bis zu 255 Zeichen lang sein und Zahlen, Unterstriche, sowie Punkte enthalten. Leerzeichen und Bindestriche werden hingegen nicht akze…

Evotec AG (EVTCY) Upgraded by Zacks Investment Research to Buy

Evotec AG (EVTCY) Upgraded by Zacks Investment Research to Buy
The brokerage currently has a $56.00 target price on the stock. Zacks Investment Research 's target price would indicate a potential upside of 20.66% from the company's previous close.

from Biotech News

GlaxoSmithKline has been ranked the worst governed company on the FTSE 100

GlaxoSmithKline has been ranked the worst governed company on the FTSE 100
A recent bribery scandal and excessive pay policies have sent pharma giant GlaxoSmithKline to the bottom of the Institute of Directors' corporate governance survey. The third annual Good Governance Index ranked GSK as the worst company among London's largest listed firms when measured against 47 indicators in five broad categories including board effectiveness, audit and risk/external accountability, remuneration, as well as shareholder and stakeholder relations.

from Biotech News

Pfizer considers consumer business sale

Pfizer considers consumer business sale
The pharmaceutical giant is weighing options for its consumer healthcare business. It may spin off or sell the unit, which also produces Advil, Preparation H and the Centrum brand of vitamins.

from Biotech News

Finanzen: VW-Abgas-Skandal - Ihre Rechte als Aktionär : Schadensersatzanspruch für VW-Aktionäre

VW-Aktionäre haben Anspruch auf Schadensersatz wegen des Abgas-Skandals. So können Sie Ihre Rechte im Musterverfahren geltend machen.

from Finanztip Feed
Supported by Video Collection

'That should be illegal': Lawmakers are taking aim at pharma giant...

'That should be illegal': Lawmakers are taking aim at pharma giant...
'That should be illegal': Lawmakers are taking aim at pharma giant Allergan over an unusual deal with a Native American tribe Allergan CEO Brent Saunders prepares to give an interview on the floor of the New York Stock Exchange April 6, 2016. In September, Allergan struck an unusual deal with the Saint Regis Mohawk Tribe to transfer patents of the eye drug Restasis, a move that gives the drug sovereign immunity from certain patent challenges.

from Biotech News

Finanzen: Fahrtenbuch : Fahrtenbuch

Ein elektronisches Fahrtenbuch ist für Dienstwagenfahrer häufig günstiger als die 1-Prozent-Regelung, um die private Nutzung zu versteuern.

from Finanztip Feed
Supported by Video Collection

UPDATE 1-California governor signs drug pricing transparency law

UPDATE 1-California governor signs drug pricing transparency law
California Governor Jerry Brown on Monday signed state legislation requiring drug companies to report certain price hikes for prescription medicines in a move that could set a model for other states to follow. The law, which aims to provide more transparency around pharmaceutical and biotech company pricing methods for their medicines, requires drug manufacturers to give a 60-day notice if prices are raised more than 16 percent over a two-year period.

from Biotech News

Mehrere Word-Dokumente zu einer Datei zusammenführen

Mehrere Word-Dokumente zu einer Datei zusammenführen
Einzel-Dokumente zu einer Datei zusammen zu führen, kann zum Beispiel bei einer Archivierung sehr nützlich sein. Alle Schriftstücke einer Zeitspanne zusammengefasst, ist für eine schnelle und effiziente Suche sehr vorteilhaft. Bei Word ist die Zusammenführung mit ein paar Klicks schnell durchgeführt.Öffne in Word die Textdatei, die an erster Stelle der neuen Datei stehen soll. Wechsle dann in die Registerkarte Einfügen und klicke in der Gruppe Text auf auf den kleinen Pfeil von Objekt. Dann aktivierst du die Funktion Text aus Datei, die ein neues Dialogfenster mit dem Namen Datei einfügen öffnet.Hier wählst du mit gedrückter [Strg]-Taste nun alle Dokumente aus, die zusammengeführt werden sollen. Sobald du auf die Schaltfläche Einfügen klickst, werden alle Textdateien zu Einer zusammengefügt.

Supported by World News Digest

Promega files counterclaim in lawsuit filed by shareholders

Promega files counterclaim in lawsuit filed by shareholders
Promega Corp. and its founder are firing back at shareholders who sued the Wisconsin biotechnology company in 2016 for shareholder oppression. The lawsuit filed by shareholders Nathan Brand and Ted Kellner alleges that company founder Bill Linton bullied shareholders in order to keep majority control of the company.

from Biotech News

NIH Awards Cerebral Amyloid Angiopathy Grant to Amydis Diagnostics

NIH Awards Cerebral Amyloid Angiopathy Grant to Amydis Diagnostics
Amydis Diagnostics, Inc., a privately-held pharmaceutical company developing proprietary chemistry and innovative approaches for the detection of amyloid-related diseases, announced today that they received a Phase 1 SBIR grant award from the National Institute on Aging of the National Institutes of Health . The grant award for more than $530,000 will fund research and development efforts for novel ophthalmic diagnostic probes for Cerebral Amyloid Angiopathy , an age-associated disease in which proteins called amyloid build up on the walls of the arteries in the brain increasing the risk for stroke caused by bleeding , and dementia .

from Biotech News

BioDelivery Sciences International, Inc. (BDSI) Expected to Post Quarterly Sales of $8.89 Million

BioDelivery Sciences International, Inc. (BDSI) Expected to Post Quarterly Sales of $8.89 Million
Equities research analysts expect BioDelivery Sciences International, Inc. to report sales of $8.89 million for the current quarter, Zacks reports. Four analysts have issued estimates for BioDelivery Sciences International's earnings, with the highest sales estimate coming in at $9.52 million and the lowest estimate coming in at $8.37 million.

from Biotech News

La Jolla earthquake on wheels

La Jolla earthquake on wheels
On September 27th, Marty Nelson, safety and environmental compliance officer at Southwest Fisheries in La Jolla, gathered his staff, along with faculty from adjacent Scripps Institution of Oceanography, to try out a magnitude 7.2 in the Big Shaker mobile earthquake simulator. The inside is designed like a living room, with a big-screen television, shelves with loose items, and benches along the sides.

from Biotech News

CDC: Rural counties have higher suicide rates than metropolitan areas in U.S.

CDC: Rural counties have higher suicide rates than metropolitan areas in U.S.
A study by the Centers for Disease Control and Prevention in Atlanta says that rural counties in the United State have higher suicide rates than metropolitan counties. The report on agency's website, https://www.cdc.gov/ , says suicide is the 10th leading cause of death in the United States and there were more than half a million during the study period.

from Biotech News

Finanzen: Anwaltskosten : Anwaltssuche und Anwaltskosten

Sie können keinen preiswerteren Anwalt finden, aber einen besseren: Wir geben Tipps zur Anwaltssuche und zur Berechnung der Anwaltskosten.

from Finanztip Feed
Supported by Video Collection

ProPhase Labs, Inc. (PRPH) Downgraded by ValuEngine to "Sell"

ProPhase Labs, Inc. (PRPH) Downgraded by ValuEngine to "Sell"
Shares of ProPhase Labs traded up 0.97% on Thursday, reaching $2.09. The company had a trading volume of 489 shares.

from Biotech News

Onkologie: 68 neue Medikamente in der Entwicklung

Onkologie: 68 neue Medikamente in der Entwicklung
Der Kampf gegen Tumorerkrankungen ist noch lange nicht gewonnen. Aber die Pharmaindustrie erweitert stetig die Zahl der Therapieoptionen. Zurzeit befinden sich 68 neue Onkologika kurz davor, zum zugelassenen Medikament zu werden. Das zeigt ein Blick in die Patentdatenbank SHARK von INSIGHT Health. D...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

RTI Surgical, Inc. (RTIX) Stock Rating Lowered by Zacks Investment Research

RTI Surgical, Inc. (RTIX) Stock Rating Lowered by Zacks Investment Research
According to Zacks, "RTI Surgical Inc. is a surgical implant company. Its implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures.

from Biotech News

Windows: Automatische Erinnerung zum Passwortwechsel einschalten

Windows: Automatische Erinnerung zum Passwortwechsel einschalten
Um den eigenen Computer gegen den Zugriff Unbefugter zu schützen, kann man bei Windows ein Passwort einrichten. Das ist ja hinlänglich bekannt. Auch die Tatsache, dass Kennwörter regelmäßig geändert werden sollten, dient der eigenen Sicherheit. Dazu kannst du dich von Windows 10 automatisch an eine Passwortänderung erinnern lassen.Öffne das Fenster Ausführen per Shortcut [Windows][R], gib den Befehl lusrmgr.msc ein, und bestätige mit der Taste [Eingabe].Im Programmfenster lusrmgr klickst du auf Benutzer und öffnest das Fenster Eigenschaften per Doppelklick auf deinen Kontoeintrag.  Hier entfernst du das Häkchen der Option Kennwort läuft nie ab. Bestätige die Änderung mit dem Button OK.Ab sofort wirst du nach 30 Tagen an die Passwortänderung erinnert. Diese Arbeitsschritte funktionieren allerdings nur mit den Pro-Versionen von Windows.Tipp:Bei Bedarf kannst du über die Eingabeaufforderung den 30-Tage-Rhythmus auch verkürze…

OMEICOS erweitert Serie-B-Finanzierung, um neue Indikationen zu adressieren

OMEICOS erweitert Serie-B-Finanzierung, um neue Indikationen zu adressieren
OMEICOS Therapeutics, eine Ausgründung des Max-Delbrück-Centrums für Molekulare Medizin in der Helmholtz-Gemeinschaft (MDC), hat das zweite Closing seiner Serie-B-Finanzierung bekanntgegeben. Neuer Investor ist der US-amerikanische Risikokapitalgeber REMIGES Venture. Mit der Finanzierung wird OMEICO...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Bitcoin vs. Biotech: Which Is the Smarter Investment?

Bitcoin vs. Biotech: Which Is the Smarter Investment?
Bitcoin just might be the most controversial topic in the investing world. Supporters think the cryptocurrency has the potential to disrupt the financial industry.

from Biotech News

Bayer AG (BAYN) PT Set at 126.00 by Sanford C. Bernstein

Bayer AG (BAYN) PT Set at 126.00 by Sanford C. Bernstein
The firm currently has a "buy" rating on the healthcare company's stock. BAYN has been the subject of a number of other research reports.

from Biotech News

Trinity Biotech PLC (TRIB) Earns Daily News Sentiment Score of 0.07

Trinity Biotech PLC (TRIB) Earns Daily News Sentiment Score of 0.07
Media stories about Trinity Biotech PLC have trended somewhat positive recently, according to Accern Sentiment. The research group ranks the sentiment of press coverage by monitoring more than 20 million news and blog sources in real-time.

from Biotech News

Fortress Biotech, Inc. (FBIO) Downgraded by ValuEngine to Sell

Fortress Biotech, Inc. (FBIO) Downgraded by ValuEngine to Sell
FBIO has been the subject of a number of other research reports. HC Wainwright set a $11.00 price objective on shares of Fortress Biotech and gave the stock a buy rating in a research report on Tuesday, July 11th.

from Biotech News

Stunning and alarming new discovery about dogs

Stunning and alarming new discovery about dogs
A new report indicates your dog may be harboring an illness that could be passed on to you if you're not careful. The Centers for Disease Control and Prevention is sounding the alarm about puppies sold in a nationwide chain of 80 pet stores that authorities have linked to 55 people getting sick, including 13 who require hospitalization.

from Biotech News

-$0.22 Earnings Per Share Expected for Spectrum Pharmaceuticals, Inc. (SPPI) This Quarter

-$0.22 Earnings Per Share Expected for Spectrum Pharmaceuticals, Inc. (SPPI) This Quarter
Equities research analysts predict that Spectrum Pharmaceuticals, Inc. will post earnings of per share for the current fiscal quarter, according to Zacks . Two analysts have provided estimates for Spectrum Pharmaceuticals' earnings, with the lowest EPS estimate coming in at and the highest estimate coming in at .

from Biotech News

Life (Science) Lessons: The Hows And Whos To Play Biotech

Life (Science) Lessons: The Hows And Whos To Play Biotech
After particularly rough endings to 2015 and 2016, iShares NASDAQ Biotechnology Index has had "a rockstar of a year," and the last two weeks, in particular, have seen significant inflows - about $400 million - into industry ETFs. "I think with respect to the pharma and the biotech industry, the current status quo is a good place for being a drug executive, because you have continuing drivers of demographics, you have continuing solid pricing, you don't have the fears of the industry pricing getting slashed, so I think people in our industry are breathing a sigh of relief," Paul Yook, co-founder of LifeSci Index Partners , said on the Sept.

from Biotech News

Amarin Corporation PLC (AMRN) Insider Steven B. Ketchum Sells 63,479 Shares

Amarin Corporation PLC (AMRN) Insider Steven B. Ketchum Sells 63,479 Shares
Amarin Corporation PLC insider Steven B. Ketchum sold 63,479 shares of the stock in a transaction that occurred on Thursday, October 5th. The stock was sold at an average price of $3.48, for a total value of $220,906.92.

from Biotech News

[Video] A Conversation on CMS' Emergency Preparedness Compliance for Healthcare Providers

[Video] A Conversation on CMS' Emergency Preparedness Compliance for Healthcare Providers
Hurricane Irma recently wreaked havoc on the Caribbean and much of the state of Florida. In the storm's aftermath, ten residents of a South Florida nursing facility died because the facility lost power, and did not have access to a backup generator.

from Biotech News

Newark sues opioid makers, alleging deceptive advertising

Newark sues opioid makers, alleging deceptive advertising
It alleges the companies downplayed the risk of opioid addiction and overstated the drugs' long-term benefits. The suit seeks unspecified monetary damages On Thursday, the state attorney general's office announced a lawsuit against Phoenix-based Insys Therapeutics, maker of a fentanyl painkiller spray.

from Biotech News

Brokerages Expect Charles River Laboratories International, Inc....

Brokerages Expect Charles River Laboratories International, Inc....
Wall Street brokerages expect Charles River Laboratories International, Inc. to post sales of $459.17 million for the current quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Charles River Laboratories International's earnings, with the highest sales estimate coming in at $471.00 million and the lowest estimate coming in at $454.50 million.

from Biotech News

'Nobody's talking about' 2 medical conditions that affect 8...

'Nobody's talking about' 2 medical conditions that affect 8...
'Nobody's talking about' 2 medical conditions that affect 8 million women in America - but that could be about to change The drugs in development are to treat two major women's health conditions, endometriosis and uterine fibroids, which can cause a lot of pain for women and in some cases lead to infertility and surgical procedures. An estimated 5 million Americans are living with endometriosis, a condition in which tissue from the uterus grows outside the uterus, leading to cysts, heavy bleeding, and scarring.

from Biotech News

Wayne State receives $2 million NIH grant for new study on fetal alcohol spectrum disorders

Wayne State receives $2 million NIH grant for new study on fetal alcohol spectrum disorders
Fetal alcohol spectrum disorders, which result from maternal alcohol use during pregnancy, is the most common preventable cause of neurodevelopmental disabilities and affects an estimated 2 percent to 5 percent of school-aged children in the United States, according to the U.S. Centers for Disease Control and Prevention.

from Biotech News

Eli Lilly Shares Spike On Patent Victory

Eli Lilly Shares Spike On Patent Victory
The U.S. Patent and Trademark Office ruled in favor of Eli Lilly and Co Thursday in an inter partes review of the '209 patent for Alimta, a chemotherapy drug for lung cancer. "Based on the record before us, we conclude that petitioner has failed to demonstrate by a preponderance of the evidence that claims 122 of the '209 patent are unpatentable," the written decision said.

from Biotech News

Anpassung der Medikamentendosis bei Rheumatoider Arthritis durch Diagnostikmethode

Изображение
Anpassung der Medikamentendosis bei Rheumatoider Arthritis durch Diagnostikmethode

Eine Zusammenarbeit zwischen dem Immanuel Klinikum Bernau Herzzentrum Brandenburg, dem Rheumazentrum Nord-Brandenburg und BioTeZ demonstriert neue Wege in der Behandlung der Rheumatoiden Arthritis. Durch die Einführung von therapeutischen Antikörpern konnten die Behandlungsergebnisse bei der Rheumat...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Finanzen: Sturm : Sturmschäden

Nach Stürmen helfen Vollkasko-, Wohngebäude- oder Hausratversicherung. Informieren Sie nach einem Schaden Ihren Versicherer so schnell wie möglich.

from Finanztip Feed
Supported by Video Collection

Car crash death rates highest in remotest rural areas

Car crash death rates highest in remotest rural areas
Car crash death rates get increasingly high as population density drops, fueled in part by lower seat belt use in the remotest rural areas, a U.S. study suggests. "We already knew that death rates were higher and seat belt use was lower in rural versus urban areas," said lead study author Laurie Beck, of the U.S. Centers for Disease Control and Prevention in Atlanta.

from Biotech News

Your Daily Pharma Scoop: The First Trust NYSE Arca Biotechnology...

Your Daily Pharma Scoop: The First Trust NYSE Arca Biotechnology...
This abridged "Daily Scoop" is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. First Trust Amex Biotechnology Index Fund is now known as First Trust NYSE Arca Biotechnology Index.

from Biotech News

Novartis AG (NVS) to Post Q3 2017 Earnings of $1.24 Per Share, Jefferies Group Forecasts

Novartis AG (NVS) to Post Q3 2017 Earnings of $1.24 Per Share, Jefferies Group Forecasts
Investment analysts at Jefferies Group issued their Q3 2017 earnings per share estimates for shares of Novartis AG in a report issued on Wednesday. Jefferies Group analyst J. Holford expects that the company will earn $1.24 per share for the quarter.

from Biotech News

$33.41 Billion in Sales Expected for Cardinal Health, Inc. (CAH) This Quarter

$33.41 Billion in Sales Expected for Cardinal Health, Inc. (CAH) This Quarter
Equities research analysts forecast that Cardinal Health, Inc. will announce $33.41 billion in sales for the current quarter, according to Zacks Investment Research . Five analysts have issued estimates for Cardinal Health's earnings, with the lowest sales estimate coming in at $32.80 billion and the highest estimate coming in at $33.85 billion.

from Biotech News

Reviewing Lombard Medical

Reviewing Lombard Medical
Lombard Medical and Neogen Corporation are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, institutional ownership, risk, dividends, earnings and profitability. Lombard Medical has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500.

from Biotech News

Neuer Stada-Chef will derzeit keine Stellen abbauen

Neuer Stada-Chef will derzeit keine Stellen abbauen
(dpa-AFX) Beim erst kürzlich von den angelsächsischen Finanzinvestoren Bain und Cinven übernommenen Arzneimittelhersteller Stada soll es vorerst keine Stellenstreichungen geben. "Ich strebe derzeit keinen Personalabbau an, weder in Deutschland noch anderswo", sagte der erst seit wenigen Tagen amtier...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

A Generic Drug Face-Off Sends Mylan Soaring 19%

A Generic Drug Face-Off Sends Mylan Soaring 19%
The surprising FDA approval of Mylan's generic version of Teva Pharmaceutical's top-selling multiple sclerosis drug Copaxone is sending shares higher today. After the Food and Drug Administration surprisingly gave a green light to the company's Copaxone knockoff, shares in Mylan Inc. As a refresher, Copaxone is the most prescribed multiple sclerosis drug and it represents about 20% of Teva Pharmaceutical's sales.

from Biotech News

Ergomed plc schließt Akquisition der PSR Group BV ab

Ergomed plc schließt Akquisition der PSR Group BV ab
Ergomed plc gibt bekannt, dass die Akquisition der PSR Group BV abgeschlossen wurde, nachdem die 2.081.389 neuen Stammaktien im Nennwert von je 1 Pence pro Aktie am 2. Oktober 2017 um 8.00 Uhr BST zum Handel an der Londoner Börse (AIM) zugelassen wurden. Insgesamt wurden 1.757.576 neue Stammaktien d...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Press release distribution, EDGAR filing, XBRL, regulatory filings

Press release distribution, EDGAR filing, XBRL, regulatory filings
It is the third consecutiv... )--Enterprise video leader Qumu has been named among the Top 20 Collaboration Technology Solution Providers for 2017 by CIOReview Magazine. Version 2.0 Celebrates Growth Milestones, Highlighted by Inclusion on Inc. 5000 List of America's Fastest Growing Private Companies )--Version 2.0 Communications today celebrates inclusion on Inc. 5000 list of America's Fastest Growing Private Companies and the addition of a new SVP.

from Biotech News

BAH fordert reduzierten Mehrwertsteuersatz auf Arzneimittel

BAH fordert reduzierten Mehrwertsteuersatz auf Arzneimittel
Die neue Bundesregierung sollte das derzeitige System der Mehrwertsteuer für Arzneimittel in Deutschland überdenken. Dies fordert Dr. Hermann Kortland, stellvertretender Hauptgeschäftsführer des Bundesverbandes der Arzneimittel-Hersteller e.V. (BAH), vor dem Hintergrund der neuen Ideen der EU-Kommis...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Endspurt für Anmeldung zum ACHEMA-Gründerpreis 2018

Endspurt für Anmeldung zum ACHEMA-Gründerpreis 2018
Der Endspurt läuft: Noch bis zum 30. November 2017 können unternehmungsfreudige Wissenschaftler, zukünftige Gründer und Inhaber von Startups mit ihren Businessplänen und Startups ins Rennen um den ACHEMA-Gründerpreis 2018 gehen. Die Finalisten haben die einmalige Chance, sich im Rahmen der ACHEMA 20...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Ergomed plc berichtet Abschluss der Akquisition der PSR Group BV

Ergomed plc berichtet Abschluss der Akquisition der PSR Group BV
Ergomed plc gibt bekannt, dass die Akquisition der PSR Group BV abgeschlossen wurde, nachdem die 2.081.389 neuen Stammaktien im Nennwert von je 1 Pence pro Aktie am 2. Oktober 2017 um 8.00 Uhr BST zum Handel an der Londoner Börse (AIM) zugelassen wurden. Insgesamt wurden 1.757.576 neue Stammaktien d...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

BioCryst Announces RAPIVAB (peramivir injection) and Galidesivir Presentations at IDWeek 2017

BioCryst Announces RAPIVAB (peramivir injection) and Galidesivir Presentations at IDWeek 2017
BioCryst Pharmaceuticals, Inc. announced today that interim results from a clinical trial of a single IV dose of RAPIVABA for the treatment of pediatric influenza and results from preclinical studies of galidesivir in Rhesus macaques models of Zika virus infection and Ebola virus infection will be presented at IDWeek 2017 a , taking place in San Diego, October 4-8, 2017. Results from a pediatric clinical trial of RAPIVABA will be presented in two poster sessions.

from Biotech News

UNH researchers tackle college sex assault, drinking

UNH researchers tackle college sex assault, drinking
Researchers at the University of New Hampshire's Prevention Innovations Research Center received a three-year grant from the National Institutes of Health to evaluate an innovative strategy to keep on-campus incidents of intimate partner violence or sexual assault from leading to problem drinking and/or mental health issues, such as depression. While research shows that a negative reaction to a disclosure of intimate partner violence or sexual assault often leads to negative outcomes, no intervention to date has been developed and evaluated specific to recipients of a disclosure.

from Biotech News

Mylan surges as its generic of Teva's Copaxone gets FDA nod

Mylan surges as its generic of Teva's Copaxone gets FDA nod
Shares of Mylan NV jumped about 17 percent in premarket trading on Wednesday after the U.S. Food and Drug Administration approved the drugmaker's copycat version of Teva Pharmaceutical Industries Ltd's blockbuster multiple sclerosis drug. Mylan's shares were trading at $38 and was top gainer among S&P 500 components trading before the opening bell.

from Biotech News

Kill Dickeyamendment

Kill Dickeyamendment
A Scranton Times-Tribune All Access subscription gets you complete access to both our print and digital publications, delivered to your home, desktop and mobile devices 7 days a week Manage your account Manage your account 24 hours a day. You can activate all access, pay your bill, update your account information, pause home delivery while you're away or ask a question.

from Biotech News

Reviewing Arena Pharmaceuticals

Reviewing Arena Pharmaceuticals
Arena Pharmaceuticals and GenVec are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, analyst recommendations, profitability, institutional ownership, dividends and valuation. 46.2% of Arena Pharmaceuticals shares are held by institutional investors.

from Biotech News

Sanitation worker killed by trash truck

Sanitation worker killed by trash truck
Authorities today released the name of a 22-year-old sanitation worker who was killed when an unoccupied trash truck rolled into him and pinned him against a wall in a La Jolla alley. David Strobridge of San Diego was moving a garbage bin in the access road off the 7600 block of Herschel Avenue when his work vehicle coasted forward and hit him shortly before 11 a.m. Monday, according to police and the county Medical Examiner's Office.

from Biotech News

Finanzen: Flugstornierung : Ansprüche durchsetzen

Flug verpasst oder storniert? Dann haben Sie Anspruch auf Erstattung von Steuern und Gebühren – eventuell sogar auf den gesamten Ticketpreis.

from Finanztip Feed
Supported by Video Collection

FDA approves new label language for Afrezza

FDA approves new label language for Afrezza
Michael Castagna, new CEO of MannKind Corporation, stands in the company's Danbury, Conn., manufacturing facility on Tuesday, June 6, 2017. Michael Castagna, new CEO of MannKind Corporation, stands in the company's Danbury, Conn., manufacturing facility on Tuesday, June 6, 2017.

from Biotech News

Finanzen: Nebenkostenabrechnung : Nebenkostenabrechnung

Nicht alle Kosten, die in einem Mietshaus anfallen, darf der Vermieter auf die Mieter umlegen. Wir zeigen, was erlaubt ist und was nicht.

from Finanztip Feed
Supported by Video Collection

Merck investiert in seinen Biotech-Produktionsstandort Bari

Merck investiert in seinen Biotech-Produktionsstandort Bari
Merck wird an seinem Produktionsstandort Bari 35 Mio. € in eine neue Produktionslinie für die aseptische Abfüllung von biotechnologisch hergestellten Arzneimitteln im Isolator investieren. Dies hat das führende Wissenschafts- und Technologieunternehmen anlässlich des 25-jährigen Bestehens des italie...

from bionity.com News | Ein Übersichtsbeitrag über Goldankauf in Berlin, Germany.

Valeant Will Release Third-Quarter 2017 Financial Results On November 7

Valeant Will Release Third-Quarter 2017 Financial Results On November 7
All materials will be made available on the investor relations section of the Valeant web site prior to the start of the call. About Valeant Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics.

from Biotech News

United Therapeutics Corporation (UTHR) Upgraded to "Buy" at ValuEngine

United Therapeutics Corporation (UTHR) Upgraded to "Buy" at ValuEngine
A number of other analysts also recently issued reports on UTHR. Oppenheimer Holdings, Inc. reaffirmed a buy rating on shares of United Therapeutics Corporation in a research note on Friday, September 8th.

from Biotech News

Federal Court of Appeal Applies Supreme Court's Utility Test to SPRYCEL Patent

Federal Court of Appeal Applies Supreme Court's Utility Test to SPRYCEL Patent
In its first decision to consider the Supreme Court of Canada's landmark decision in AstraZeneca Canada Inc v Apotex Inc , 2017 SCC 36 [ Esomeprazole ] on the utility requirement, the Federal Court of Appeal has overturned a finding of inutility made under the promise doctrine, with practical guidance for the requirement of a scintilla of utility: Bristol-Myers Squibb v Apotex , 2017 FCA 190 . The compound dasatinib is sold by Bristol-Myers Squibb as SPRYCEL, a drug used in the treatment of chronic myelogenous leukemia .

from Biotech News

Oncolytics Biotech (ONCY) Receiving Somewhat Favorable Press Coverage, Accern Reports

Oncolytics Biotech (ONCY) Receiving Somewhat Favorable Press Coverage, Accern Reports
Headlines about Oncolytics Biotech have been trending somewhat positive this week, according to Accern Sentiment. The research group rates the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time.

from Biotech News

Health Tip: Managing Epilepsy in Children

Health Tip: Managing Epilepsy in Children
About 470,000 children aged 17 or younger have epilepsy in the United States, the Centers for Disease Control and Prevention says.

from Biotech News

U.S. judge dismisses ex-sleuths' lawsuit against GlaxoSmithKline

U.S. judge dismisses ex-sleuths' lawsuit against GlaxoSmithKline
A U.S. judge has dismissed a lawsuit by two former corporate investigators who accused GlaxoSmithKline Plc of misleading them into investigating a whistleblower in China, leading to their arrest amid a bribery scandal involving the drugmaker. U.S. District Judge Nitza Quinones Alejandro in Philadelphia on Friday threw out the case by British investigator Peter Humphrey and his American wife, Yu Yingzeng, who were arrested in 2013 in China after GSK hired them to look into a former employee.

from Biotech News

Carlisle Companies to buy TyrFil parent Accella

Carlisle Companies to buy TyrFil parent Accella
Carlisle Companies Inc. has agreed to buy Accella Performance Materials, a developer of polyurethane elastomer and foam systems - including the TyrFil flatproofing tire-fill business - from Arsenal Capital Partners for $670 million. Maryland Heights-based Accella has annualized revenue of approximately $430 million and estimated EBITDA margins approaching 15 percent.

from Biotech News

Xenetic Biosciences Provides Update on Annual Meeting of Stockholders

Xenetic Biosciences Provides Update on Annual Meeting of Stockholders
Updated materials and date for the rescheduled meeting are currently being considered by the Company's Board of Directors. Stockholders will receive new proxy materials and vote on the updated proposals to be set forth in Xenetic's definitive proxy statement on Schedule 14A, which will be amended or supplemented to include the updated proposals.

from Biotech News

West Nile Virus-related death confirmed in Chatham County

West Nile Virus-related death confirmed in Chatham County
There has been a total of 31 confirmed human cases and five deaths in Georgia this year. According to the Centers for Disease Control and Prevention, about 8 in 10 of people infected with WNV will show no symptoms at all; about 1 in 5 will develop a fever, headache, body aches, joint pains, vomiting, diarrhea, or rash; and about 1 in 150 will develop a severe illness affecting the central nervous system.

from Biotech News

3 Things In Biotech You Should Learn Today: October 2, 2017

3 Things In Biotech You Should Learn Today: October 2, 2017
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. In 2017, one of the more powerful undercurrents has been the development of treatment options for early-stage HER2-positive breast cancer, specifically after surgery .

from Biotech News

UofL gets nearly $14M grant to study heart stem cells

UofL gets nearly $14M grant to study heart stem cells
The university says the grant is one of the largest for medical research in the school's history. The $13.8 million award from the National Institutes of Health is for the study of a new type of adult cardiac stem cell.

from Biotech News

Pilot who crashed at Lake Elmo Airport denied $27M verdict

Pilot who crashed at Lake Elmo Airport denied $27M verdict
In this Sept. 6, 2017 photo, Mark Kedrowski looks over a framed Certificate of Participation from the 1999 Olympic Trials in his White Bear Lake, Minn.

from Biotech News

Finanzen: Billiger telefonieren ins Ausland : Billiger telefonieren ins Ausland

Wer mit Freunden oder Familie im Ausland telefoniert, zahlt oft einen hohen Preis. Wir stellen günstige Alternativen vor.

from Finanztip Feed
Supported by Video Collection

Finanzen: Erbausschlagung : Ratgeber Erbausschlagung

Wer etwas erbt, erhält nicht nur das Vermögen, sondern auch die Schulden des Verstorbenen. Wir erklären, wann es sich lohnt, das Erbe auszuschlagen.

from Finanztip Feed
Supported by Video Collection

Finanzen: Dashcam und rechtliche Bewertung : Videoüberwachung

Eine Kamera im Auto oder am Helm kann vor Gericht helfen, wenn es kracht. Doch nicht immer werden die Aufnahmen als Beweis zugelassen.

from Finanztip Feed
Supported by Video Collection

Finanzen: Entschädigung bei Flugverspätung : Passagierrechte Flugverspätung

Bis zu 600 Euro können Sie bekommen, wenn Ihr Flieger zu spät ankommt – auch noch drei Jahre später. Ermitteln Sie mit unserem Rechner Ihre Ansprüche.

from Finanztip Feed
Supported by Video Collection